Caris Life Sciences Inc. (NASDAQ:CAI) shares are up during Friday’s premarket session following better-than-expected fourth-quarter earnings and a significant interim readout from the company’s Achieve 1 study.Sales More Than DoubledCaris Life Sciences on Thursday reported fourth-quarter earnings of 28 cents compared to the consensus loss of 3 cents.Sales for the quarter jumped 125% year over year to $292.89 million, beating the consensus of $208.63 million.The increase was driven primarily by a 199% growth ...